To check Effectiveness of 2 chloroprocaine and bupivacaine for short duration Infraumbilical surgeries

2-chloroprocaine and bupivacaine for infraumbilical short duration surgeries : a prospective observational study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/07/014932

Enrollment

100

Registered

2018-07-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Infraumbilical short duration surgery

Interventions

Intervention1: Bupivacaine: 0.5 % Hyperbaric drug Long acting local anaesthetic agent Central neuraxial (intrathecal) administration Control Intervention1: 2 chloroprocaine: Very short acting local an

Eligibility

Inclusion criteria

Inclusion criteria: Weight 50 to 70 kg ASA GRADE 1 AND 2

Exclusion criteria

Exclusion criteria: Spine deformities Prolonged major surgeries Coagulation abnormalities

Design outcomes

Primary

Measure	Time frame
Duration of anaesthesia an restriction of movementTimepoint: End of surgery At 1.5 hrs after giving spinal 2 hrs 2.5 hrs	—

Secondary

Measure	Time frame
Any complications like urinary retension Transient Neurological SymptomsTimepoint: 6 hrs after surgery 10 hrs after surgery 10th day At end of 3rd month	—

Countries

India

Contacts

Public ContactRaviraj Dhondiram Kamble

Government Medical College, Miraj

drraviraj.mdanaesthesia@gmail.com8983399475

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026